- Home
- NTRA vs STM Comparison
NTRA vs STM Comparison
Compare NTRA & STM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRA
- STM
- Stock Information
- Founded
- NTRA 2003
- STM 1987
- Country
- NTRA United States
- STM Netherlands
- Employees
- NTRA N/A
- STM N/A
- Industry
- NTRA Medical Specialities
- STM Semiconductors
- Sector
- NTRA Health Care
- STM Technology
- Exchange
- NTRA Nasdaq
- STM Nasdaq
- Market Cap
- NTRA 18.4B
- STM 22.0B
- IPO Year
- NTRA 2015
- STM 1994
- Fundamental
- Price
- NTRA $143.94
- STM $22.16
- Analyst Decision
- NTRA Strong Buy
- STM Buy
- Analyst Count
- NTRA 17
- STM 10
- Target Price
- NTRA $179.00
- STM $34.30
- AVG Volume (30 Days)
- NTRA 1.9M
- STM 7.0M
- Earning Date
- NTRA 05-08-2025
- STM 04-24-2025
- Dividend Yield
- NTRA N/A
- STM 1.63%
- EPS Growth
- NTRA N/A
- STM N/A
- EPS
- NTRA N/A
- STM 1.66
- Revenue
- NTRA $1,696,911,000.00
- STM $13,269,000,000.00
- Revenue This Year
- NTRA $13.56
- STM N/A
- Revenue Next Year
- NTRA $18.11
- STM $15.61
- P/E Ratio
- NTRA N/A
- STM $12.76
- Revenue Growth
- NTRA 56.75
- STM N/A
- 52 Week Low
- NTRA $83.13
- STM $21.36
- 52 Week High
- NTRA $183.00
- STM $45.39
- Technical
- Relative Strength Index (RSI)
- NTRA 41.35
- STM 35.14
- Support Level
- NTRA $146.35
- STM $23.59
- Resistance Level
- NTRA $155.64
- STM $24.57
- Average True Range (ATR)
- NTRA 6.42
- STM 0.58
- MACD
- NTRA 0.87
- STM -0.31
- Stochastic Oscillator
- NTRA 51.93
- STM 2.70
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
About STM STMicroelectronics N.V.
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.